Global Psoriasis Treatment Market is Expected to Reach a Market Value of USD 15.09 Billion by 2027

Psoriasis Treatment Market is estimated to grow at 7.35% for the forecast period of 2020-2027 with factor such as high charge of drug development and most treatments are not permanent and only control the symptoms and not treat the disease itself which will hamper the growth of the market in developing economies. 

Psoriasis treatment market has shown an exceptional penetration in developed economies in North America due to existence of major manufacturers, and growing prevalence of psoriasis will drive the growth of the market.

Blood Plasma Market Scenario

According to Data Bridge Market Research, the psoriasis treatment market is perceiving a significant growth in developing economies during the forecast period of 2020-2027 owing to factors such increasing prevalence of the condition, growing incidences of the autoimmune diseases, rising the availability of biologics and biosimilars, growing awareness about the disease, change in lifestyle are the factors which will boost the growth of the market. 

Now the question is which are the other regions that psoriasis treatment market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific psoriasis treatment market in the forecast period of 2020-2027 due to increasing participation of market players and the rising geriatric population. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the psoriasis treatment market.

For more analysis on the psoriasis treatment market request for a briefing with our analysts

Scope of the Psoriasis Treatment Market

Psoriasis treatment market is segmented on the basis of countries into the U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia-Pacific (APAC) as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel,  Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of the psoriasis treatment market is further analysed based on maximum granularity into further segmentation. On the basis of drug class, the market is segmented into corticosteroids, TNF inhibitors, interleukins and others. On the basis of type, the market is segmented into plaque psoriasis, psoriatic arthritis and others. On the basis of route of administration, the market is segmented into oral, parenteral and topical. On the basis of application, the market is segmented into topical therapeutic drugs, systemic therapeutic drugs and combinations. On the basis of end user, the market is segmented into topical hospital pharmacy, clinics, retail pharmacies and online sales.
  • Psoriasis is a long lasting autoimmune disease characterized by patches of abnormal skin growth, typically red, dry, heart attack and scaly skin patches. Psoriasis treatment is widely used in applications such as systemic therapeutic drugs, topical therapeutic drugs and combinations.

To know more about the study

Key Pointers Covered in the Psoriasis Treatment Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Regulatory Framework and Changes
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Eli Lilly & Company
  • Pfizer Inc.
  • Janssen Global Services LLC
  • Celgene Corporation
  • Takeda Pharmaceutical Company Limited
  • Novartis International AG
  • Amgen Inc.
  • Biogen Inc.
  • Abbvie Inc.
  • AstraZeneca
  • Boeringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc.
  • Merck & Co. Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Stiefel Laboratories
  • UCB S.A
  • LEO Pharma
  • Cipla Inc.
  • Rowan Bioceuticals
  • Glenmark Pharmaceuticals
  • Win-Medicare Pvt. Ltd.

Above are the key players covered in the report, to know about more and exhaustive list of psoriasis treatment companies’ contact us

Research Methodology: Global Psoriasis Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Report

Browse in Healthcare Category Related Reports@